Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05462561 · ClinicalTrials.gov registry record · NA
Vascularized Composite Bladder Allograft Transplantation
A NA study of Neurogenic Bladder and Immunosuppression, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT05462561 is a NA study of Neurogenic Bladder and Immunosuppression that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 5 participants, below the 93-participant average among 16 other Neurogenic Bladder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05462561, a NA study of Neurogenic Bladder and Immunosuppression, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase 0 trial tests the feasibility, functionality, and sustainability of vascularized composite bladder allograft transplantation in treating patients with terminal bladder pathology. A vascularized bladder allograft transplantation may provide a more durable and better-tolerated alternative to standard urinary diversion, which employs bowel. A robotic surgical approach will be employed.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- PROCEDURE Robotic Vascularized Composite Bladder Allograft Transplantation
Study Locations (1)
California
- USC / Norris Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2028-10-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05462561
The ClinicalTrials.gov registry entry for NCT05462561 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 93-participant average among 16 other Neurogenic Bladder trials with a reported enrollment target (95% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Neurogenic Bladder appearing as the primary indexed condition, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT05462561 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05462561 about?
NCT05462561 is a clinical study titled "Vascularized Composite Bladder Allograft Transplantation". This phase 0 trial tests the feasibility, functionality, and sustainability of vascularized composite bladder allograft transplantation in treating patients with terminal bladder pathology. A vascularized bladder allograft transplantation may provide a more durable and better-tolerated alternative t...
What is the current status of trial NCT05462561?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2023-05-01. Estimated completion is 2028-10-03.
What conditions does trial NCT05462561 study?
This clinical trial studies the following conditions: Neurogenic Bladder, Immunosuppression, Bladder Dysfunction.
What interventions are being tested in trial NCT05462561?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Robotic Vascularized Composite Bladder Allograft Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT05462561?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05462561 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurogenic Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
-
Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life
RECRUITING · NA
-
Electrical Stimulation for Continence After Spinal Cord Injury
ACTIVE NOT RECRUITING · NA
-
Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation
COMPLETED · NA
-
Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study
COMPLETED · NA
-
Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.